This web site is not optimized for Internet Explorer 6. You may notice
decreased functionality compared to other web browsers. Please follow the
link below to upgrade to a new version of Internet Explorer.

The "Yes" link below will take you out of the Abbott Laboratories family of websites.
Links which take you out of Abbott Laboratories worldwide web sites are not under the
control of Abbott Laboratories, and Abbott Laboratories is not responsible for the
contents of any such site or any further links from such site. Abbott Laboratories is
providing these links to you only as a convenience, and the inclusion of any link does
not imply endorsement of the linked site by Abbott Laboratories.

Do you wish to leave this site?
 

About Abbott Vascular

Abbott Vascular, a division of Abbott, is a global leader in cardiac and vascular care with market-leading products and an industry-leading pipeline. Headquartered in Northern California, we are committed to advancing patient care by transforming the treatment of vascular disease through medical device innovations, investments in research and development, and physician training and education.

We offer cutting-edge devices for coronary artery disease, peripheral vascular disease, carotid artery disease and structural heart disease. Our flagship product is the market-leading XIENCE V Everolimus Eluting Coronary Stent System a drug eluting stent for the treatment of coronary artery disease. In addition, our comprehensive product portfolio includes bare metal stents, balloon catheters, guide wires and vessel closure devices.

 

AP2932968 Rev. B